$330.21
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 56,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Country

US

CEO

Mr. Kevin Lobo

IPO date

1980

Employees

56,000

ISIN

US8636671013

Key stats

Open

$328.06

Volume

1.95M

Market cap

$125.40B

Prev. close

$327.11

Impl / hst vl

-

Open interest

$0.00

$327.00

Day’s Range

$331.57

$281.00

52W Range

$388.67

Valuation

44
Valuation score
Fairly Valued
P/E
37.74
P/S
4.98
P/B
5.48
Current ratio
2.11
Debt / Equity
0.52
ROE
15.10%
Gross margin
63.57%
Income growth
-12.25%
FCF growth
-77.87

Jul

31

Dividends

The last payment date was Jul 31, 2026

Div. per Share

$0.88

Div. Yield

0.27%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 14 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$395.01
The top 31 analysts forecasts that 12-month price may increase by 19.62%, with a low of $318.15 and a high of $488.25
$318.15
Low
$395.01
Avg
$488.25
High
Current price

Earnings

Q1 ‘26 revenue
$6.02B
Q1 ‘26 net income
$745.00M
Revenue
Net income
Previous EPS
$2.60
Estimate EPS
$3.52
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply